slotkoers
Shenzhen S.E.
00:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
31,3
CNY
|
+1,52%
|
|
-6,26%
|
-15,97%
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Marktkapitalisatie
1 |
70.798
|
35.164
|
30.011
|
21.889
|
18.277
|
-
|
Bedrijfswaarde
1 |
70.798
|
35.164
|
30.011
|
21.889
|
18.277
|
18.277
|
K/w-verhouding
|
17
x
|
28,3
x
|
18,3
x
|
38
x
|
14,5
x
|
12,1
x
|
Dividendrendement
|
1,08%
|
1,09%
|
2,66%
|
1,34%
|
2,68%
|
3,25%
|
Marktkapitalisatie/omzet
|
5,65
x
|
4,38
x
|
2,64
x
|
2,67
x
|
1,85
x
|
1,64
x
|
Bedrijfswaarde/omzet
|
5,65
x
|
4,38
x
|
2,64
x
|
2,67
x
|
1,85
x
|
1,64
x
|
Bedrijfswaarde/EBITDA
|
14,8
x
|
18,4
x
|
13
x
|
18,4
x
|
9,23
x
|
8,01
x
|
Bedrijfswaarde/FCF
|
-
|
110
x
|
16,2
x
|
52,3
x
|
20,6
x
|
17,4
x
|
FCF Yield
|
-
|
0,91%
|
6,16%
|
1,91%
|
4,86%
|
5,76%
|
Price to Book
|
6,77
x
|
3,29
x
|
2,61
x
|
1,92
x
|
1,31
x
|
1,22
x
|
Aantal aandelen (in duizenden)
|
597.089
|
597.089
|
587.633
|
587.633
|
583.938
|
-
|
Referentieprijs
2 |
118,6
|
58,89
|
51,07
|
37,25
|
31,30
|
31,30
|
Datum van publicatie
|
19/04/21
|
21/04/22
|
24/04/23
|
24/04/24
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Omzet
1 |
4.575
|
12.534
|
8.037
|
11.351
|
8.185
|
9.879
|
11.170
|
EBITDA
1 |
-
|
4.789
|
1.908
|
2.316
|
1.188
|
1.980
|
2.281
|
Bedrijfsresultaat (EBIT)
1 |
-
|
4.532
|
1.476
|
1.977
|
818
|
1.475
|
1.756
|
Operationele Marge
|
-
|
36,16%
|
18,36%
|
17,41%
|
9,99%
|
14,93%
|
15,72%
|
Resultaat voor belastingen (EBT)
1 |
-
|
4.502
|
1.463
|
1.920
|
749,8
|
1.457
|
1.737
|
Nettowinst (verlies)
1 |
546,3
|
3.810
|
1.239
|
1.651
|
580,4
|
1.221
|
1.456
|
Nettomarge
|
11,94%
|
30,4%
|
15,42%
|
14,54%
|
7,09%
|
12,36%
|
13,03%
|
WPA
2 |
1,036
|
6,993
|
2,079
|
2,786
|
0,9800
|
2,163
|
2,577
|
Free Cash Flow
1 |
-
|
-
|
319,4
|
1.847
|
418,3
|
888
|
1.052
|
FCF-marge
|
-
|
-
|
3,97%
|
16,27%
|
5,11%
|
8,99%
|
9,42%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
16,74%
|
79,75%
|
35,2%
|
44,86%
|
46,12%
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
25,77%
|
111,92%
|
72,07%
|
72,75%
|
72,27%
|
Dividend per aandeel
2 |
-
|
1,286
|
0,6429
|
1,357
|
0,5000
|
0,8400
|
1,018
|
Datum van publicatie
|
27/08/20
|
19/04/21
|
21/04/22
|
24/04/23
|
24/04/24
|
-
|
-
|
Fiscaal tijdperk: december |
2021 S1
|
2021 Q4
|
2022 Q1
|
2022 Q3
|
---|
Omzet
1 |
4.060
|
2.217
|
-
|
2.484
|
EBITDA
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
|
-
|
-
|
-
|
-
|
Operationele Marge
|
-
|
-
|
-
|
-
|
Resultaat voor belastingen (EBT)
|
-
|
-
|
-
|
-
|
Nettowinst (verlies)
|
761
|
135,3
|
357,1
|
-
|
Nettomarge
|
18,75%
|
6,1%
|
-
|
-
|
WPA
|
-
|
-
|
0,6000
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
29/09/21
|
21/04/22
|
21/04/22
|
24/10/22
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
319
|
1.847
|
418
|
888
|
1.052
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
64,7%
|
11,8%
|
14,9%
|
5,03%
|
9,13%
|
10,2%
|
ROA (netto-inkomsten/totale activa)
|
-
|
43,5%
|
9,44%
|
9,91%
|
-
|
6,25%
|
7,23%
|
Totale activa
1 |
-
|
8.767
|
13.134
|
16.657
|
-
|
19.539
|
20.125
|
Nettoactief per aandeel
2 |
-
|
17,50
|
17,90
|
19,60
|
19,40
|
24,00
|
25,70
|
Cashflow per aandeel
2 |
-
|
7,980
|
1,460
|
5,000
|
1,790
|
2,420
|
3,240
|
Capex
1 |
-
|
327
|
552
|
1.136
|
645
|
701
|
593
|
Capex/omzet
|
-
|
2,61%
|
6,87%
|
10,01%
|
7,88%
|
7,1%
|
5,3%
|
Datum van publicatie
|
27/08/20
|
19/04/21
|
21/04/22
|
24/04/23
|
24/04/24
|
-
|
-
|
Laatste slotkoers
31,3
CNY Gemiddelde koersdoel
42,33
CNY Spread / Gemiddelde doel +35,25% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -15,97% | 2,52 mld. | | +11,84% | 27,79 mld. | | -32,98% | 2,98 mld. | | +11,90% | 2,34 mld. | | -1,11% | 1,91 mld. | | -13,37% | 1,83 mld. | | -7,78% | 1,39 mld. | | -0,38% | 1,27 mld. | | +4,01% | 1,13 mld. | | +13,51% | 1,12 mld. |
Medische benodigdheden
|